NDC 73309-121 - Cefadroxil Monohydrate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73309-121
- Package NDCs from labels
- 73309-121-01, 73309-121-02
- Manufacturer
- BLUEBAY SHANDONG CO.,LTD
- Effective date
- 2021-07-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cefadroxil Monohydrate - BLUEBAY SHANDONG CO.,LTD | BLUEBAY SHANDONG CO.,LTD | 2021-07-08 | BULK INGREDIENT |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73309-121-01 | Cefadroxil Monohydrate | 1 kg in 1 JAR | POWDER | 1 | 2 | |
| 73309-121-02 | Cefadroxil Monohydrate | 0.1 kg in 1 JAR | POWDER | 0.1 | 2 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cefadroxil | CEFADROXIL | NuCare Pharmaceuticals,Inc. | a218d8d3-af90-4599-e053-2995a90a0ede | 2024-06-20 | Warnings, Adverse reactions | 280111G160 |
| Cefadroxil | CEFADROXIL | NuCare Pharmaceuticals,Inc. | 8bdd68a4-4e2e-0170-e053-2a95a90adb78 | 2024-06-18 | Warnings, Adverse reactions | 280111G160 |
| Cefadroxil | CEFADROXIL | NuCare Pharmaceuticals,Inc. | 7278a39f-9de1-c9e2-e053-2a91aa0aea34 | 2024-06-10 | Warnings, Adverse reactions | 280111G160 |
| Cefadroxil | CEFADROXIL | Advanced Rx Pharmacy of Tennessee, LLC | 1a50b564-b00f-58e4-e063-6294a90af2c6 | 2024-06-07 | Warnings, Adverse reactions | 280111G160 |
| Cefadroxil | CEFADROXIL | NuCare Pharmaceuticals,Inc. | 16f3dd01-650a-2426-e063-6394a90a1b4b | 2024-04-25 | Warnings, Adverse reactions | 280111G160 |
| Cefadroxil | CEFADROXIL | Bryant Ranch Prepack | 672519a7-11a1-4d8e-b2ca-dc9598c2f179 | 2024-04-03 | Warnings, Adverse reactions | 280111G160 |
| Cefadroxil | CEFADROXIL | Bryant Ranch Prepack | 9c3bed82-6df0-4643-944a-a826f7dc018f | 2024-04-03 | Warnings, Adverse reactions | 280111G160 |
| Cefadroxil | CEFADROXIL | Bryant Ranch Prepack | 8cdaac56-b84a-4b6b-b94d-cab15d5961c5 | 2024-04-03 | Warnings, Adverse reactions | 280111G160 |
| Cefadroxil | CEFADROXIL | A-S Medication Solutions | 41ab333a-fafb-4647-844e-f3b2a76723cb | 2024-02-15 | Warnings, Adverse reactions | 280111G160 |
| Cefadroxil | CEFADROXIL | Advanced Rx Pharmacy of Tennessee, LLC | ec836a53-7ed1-79b9-e053-2a95a90a9c36 | 2024-02-09 | Warnings, Adverse reactions | 280111G160 |
| Cefadroxil | CEFADROXIL | NorthStar Rx LLC | 30bb3686-87b4-4676-9ff5-e20deb8bff9d | 2024-02-09 | Warnings, Adverse reactions | 280111G160 |
| Cefadroxil | CEFADROXIL | Rising Pharma Holdings, Inc. | 6e4111d3-f11b-403c-b340-b216022709df | 2024-02-09 | Warnings, Adverse reactions | 280111G160 |
| Cefadroxil | CEFADROXIL | Aurobindo Pharma Limited | 776a8dbc-e68e-4732-acf4-0133dca0f54c | 2024-02-09 | Warnings, Adverse reactions | 280111G160 |
| Cefadroxil | CEFADROXIL | Rising Pharma Holdings, Inc. | 74c99fd8-16d1-4d2c-9158-42ff5eed2b7c | 2024-01-30 | Warnings, Adverse reactions | 280111G160 |
| Cefadroxil | CEFADROXIL | Aurobindo Pharma Limited | 7bb90096-14d3-400e-94d3-048bff6b1292 | 2024-01-30 | Warnings, Adverse reactions | 280111G160 |
| Cefadroxil | CEFADROXIL | NorthStar Rx LLC | 17123057-58c7-401a-b87d-8c4c0764bbf6 | 2024-01-30 | Warnings, Adverse reactions | 280111G160 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.